NLM logo
450 results
  1. ... fitness rather than age. 4.1.3. Treating advanced-stage asymptomatic follicular lymphoma Follicular lymphoma has a long natural history. The ... m2 at weekly intervals. 4.1.4. Treating advanced-stage symptomatic follicular lymphoma NICE has developed a suite of technology appraisal ...
  2. ... with deferred chemotherapy (watch and wait) in treating advanced asymptomatic follicular lymphoma B.1. Background Follicular lymphoma has a long ... of the following management strategies for people with advanced asymptomatic follicular lymphoma: Watchful ... induction Rituximab induction and maintenance ...
  3. ... chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children' ... Laver JH, Kraveka JM, Hutchison RE, et al.: Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized ...
  4. ... Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative ... and detection of relapse in intermediate-stage and advanced-stage Hodgkin lymphoma. Most relapses occurred within the first year after ...
  5. ... Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma ). Funded by Millenium Pharmaceuticals Ltd. No involvement in ... FDG-PET imaging in patients with newly diagnosed, advanced Hodgkin's lymphoma ). Funded by CRUK Non-personal financial Non-specific ...
  6. ... FDG-PET imaging in patients with newly diagnosed, advanced Hodgkin's lymphoma). Funded by CRUK Non-personal pecuniary, Non-specific ... brentuximab vedotin in the first line treatment of advanced classic Hodgkin lymphoma. Funded by Takeda. Non-personal pecuniary, Non-specific ...
  7. ... wait) the more effective treatment for people with advanced asymptomatic follicular lymphoma? Literature search details Database name Dates Covered No ...
  8. ... et al.: Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 112 (8): 3082- ... is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin ...
  9. ... in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders) : NCI-COG Pediatric Molecular Analysis ...
  10. ... in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders) : NCI–Children's Oncology Group ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last